The TGFβ dysregulation, fibrosis and dermal accumulation of microfibril aggregates observed in SSS and the acromelic dysplasias would then be a secondary response to an altered signalling program initiated by changes in the surface interactions with microfibrils. Here, TGFB1 is linked to acromelic dysplasia.